HOME PAGE
`Sequential' opposition delaying drug patents
Pharma majors take up the issue with Centre
More
`H-1B fee paid by US cos funds scholarships'
Study says skilled foreign-born professionals essential for competitiveness of US companies
More
Prime car models on phase-out mode
Lower demand, cannibalising sales of newer models main reasons
More
Aurobindo Pharma eyeing more acquisitions
To spend $300 m for Europe, US forays
More
Essar to pump in Rs 1,500 cr fresh equity
The Essar group will pump in via Mauritius, fresh equity worth Rs 1,500 crore, in the group companies. According to company sources, the funds would be utilised partly for repaying of liabilities and partly to meet the costs of the various ...
More
Positive momentum may continue
Significant amount of emerging markets money likely to enter here
More
Novel themes - Will performance tell their fancy?
NFOs and the ideas they seek to capture have made headlines time and again
More
Liquidity woes, soaring crude pull down bonds
Selling intensifies with the inclusion of recap bonds in SLR basket
More
Firms no longer coy about outsourcing
India card turns USP for product development
More
Cricket is not your property, COAI tells Board
SMS UPDATES
More
`Chennai heading for acute housing shortage'
Infrastructure crunch to be stretched to the limits
More
Advt Links:
•
Personal Computing resources
•
Hawaii Vacations - Hanalei Bay Resort
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
RSS Feeds
